Home » Newsletters » BioWorld Science

BioWorld Science

April 6, 2005

View Archived Issues

Anti-RSV agent with a novel mechanism identified

Maxygen earns milestone in alliance with Roche

Dietary DHA could be beneficial for AD

Metabasis updates CS-917 trials status

Potent EAAT2 inhibitors synthesized by Taisho

Tie-2 inhibitor with good in vivo profile effective in a murine model of angiogenesis

Biolipox claims novel antiinflammatory indole compounds

New agents for the treatment of lipoprotein disorders reported by Forbes Medi-Tech

Novel antidiabetic agents imparted by Roche

Clinical trials confirm the good safety profile and low immunogenicity of DX-88

Update on the therapeutic benefits of ciclesonide in asthma

Clinical evidence for the anxiolytic effects of LY-544344

Update: Cancer treatment with Gendicine, the first approved gene therapy

Chugai ceases development of orlistat in Japan

Oncotherapy Science to begin clinical trial for OTS-102

Hemosol to produce iron-binding drugs for Biomedical Frontiers

Hollis-Eden initiates phase I study for Neumune

Critical Therapeutics submits sNDA for Zyflo

Genentech files IND for basal cell carcinoma drug candidate

TAK-187 superior to benznidazole in Chagas' disease model

Migenix receives investment commitment from Technology Partnerships Canada

AnorMED files IND to study AMD-3100 in cardiac patients

Interferon-beta may block viral asthma exacerbations

Alkermes submits Vivitrex NDA

Not approvable letter for cilansetron for IBS-D

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...